Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Thimerosal-Preserved Hepatitis B Vaccine and Hyperkinetic Syndrome of Childhood.

Geier DA, Kern JK, Hooker BS, Sykes LK, Geier MR.

Brain Sci. 2016 Mar 15;6(1). pii: E9. doi: 10.3390/brainsci6010009.

2.

A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders.

Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR.

Int J Environ Res Public Health. 2014 Sep 5;11(9):9156-70. doi: 10.3390/ijerph110909156.

3.

A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States.

Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR.

Transl Neurodegener. 2013 Dec 19;2(1):25. doi: 10.1186/2047-9158-2-25.

4.

Thimerosal exposure and increased risk for diagnosed tic disorder in the United States: a case-control study.

Geier DA, Kern JK, Hooker BS, King PG, Sykes LK, Homme KG, Geier MR.

Interdiscip Toxicol. 2015 Jun;8(2):68-76. doi: 10.1515/intox-2015-0011.

5.

Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.

Young HA, Geier DA, Geier MR.

J Neurol Sci. 2008 Aug 15;271(1-2):110-8. doi: 10.1016/j.jns.2008.04.002. Epub 2008 May 15.

PMID:
18482737
6.
7.

Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink.

Geier DA, Kern JK, Homme KG, Sykes LK, Geier MR.

N Am J Med Sci. 2016 Jul;8(7):297-306. doi: 10.4103/1947-2714.187148.

8.
9.

Thimerosal exposure & increasing trends of premature puberty in the vaccine safety datalink.

Geier DA, Young HA, Geier MR.

Indian J Med Res. 2010 Apr;131:500-7.

10.

Thimerosal exposure and disturbance of emotions specific to childhood and adolescence: A case-control study in the Vaccine Safety Datalink (VSD) database.

Geier DA, Kern JK, Homme KG, Geier MR.

Brain Inj. 2017;31(2):272-278. doi: 10.1080/02699052.2016.1250950. Epub 2017 Jan 19.

PMID:
28102704
11.
12.

A cross-sectional study of the relationship between infant Thimerosal-containing hepatitis B vaccine exposure and attention-deficit/hyperactivity disorder.

Geier DA, Kern JK, Homme KG, Geier MR.

J Trace Elem Med Biol. 2018 Mar;46:1-9. doi: 10.1016/j.jtemb.2017.11.001. Epub 2017 Nov 8.

PMID:
29413097
13.

A longitudinal cohort study of the relationship between Thimerosal-containing hepatitis B vaccination and specific delays in development in the United States: Assessment of attributable risk and lifetime care costs.

Geier DA, Kern JK, Hooker BS, King PG, Sykes LK, Geier MR.

J Epidemiol Glob Health. 2016 Jun;6(2):105-18. doi: 10.1016/j.jegh.2015.06.002. Epub 2015 Jul 9.

14.

Thimerosal-containing hepatitis B vaccination and the risk for diagnosed specific delays in development in the United States: a case-control study in the vaccine safety datalink.

Geier DA, Kern JK, Hooker BS, King PG, Sykes LK, Geier MR.

N Am J Med Sci. 2014 Oct;6(10):519-31. doi: 10.4103/1947-2714.143284.

15.

A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis.

Geier DA, Geier MR.

Med Sci Monit. 2005 Apr;11(4):CR160-70. Epub 2005 Mar 24.

PMID:
15795695
16.

[Lack of association between thimerosal-containing vaccines and autism].

Mrozek-Budzyn D, Majewska R, Kiełtyka A, Augustyniak M.

Przegl Epidemiol. 2011;65(3):491-5. Polish.

PMID:
22184954
17.

The risk of neurodevelopmental disorders following Thimerosal-containing Hib vaccine in comparison to Thimerosal-free Hib vaccine administered from 1995 to 1999 in the United States.

Geier DA, Kern JK, Homme KG, Geier MR.

Int J Hyg Environ Health. 2018 May;221(4):677-683. doi: 10.1016/j.ijheh.2018.03.004. Epub 2018 Mar 14.

PMID:
29573974
18.

Lead, mercury, and cadmium exposure and attention deficit hyperactivity disorder in children.

Kim S, Arora M, Fernandez C, Landero J, Caruso J, Chen A.

Environ Res. 2013 Oct;126:105-10. doi: 10.1016/j.envres.2013.08.008. Epub 2013 Sep 10.

19.

Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children.

Lahey BB, Pelham WE, Chronis A, Massetti G, Kipp H, Ehrhardt A, Lee SS.

J Child Psychol Psychiatry. 2006 May;47(5):472-9.

PMID:
16671930
20.

Vitamin D in Pregnancy and Attention Deficit Hyperactivity Disorder-like Symptoms in Childhood.

Morales E, Julvez J, Torrent M, Ballester F, Rodríguez-Bernal CL, Andiarena A, Vegas O, Castilla AM, Rodriguez-Dehli C, Tardón A, Sunyer J.

Epidemiology. 2015 Jul;26(4):458-65. doi: 10.1097/EDE.0000000000000292.

PMID:
25867115

Supplemental Content

Support Center